BRPI0413132A - composições e compostos bicìclicos como inibidores de pdf - Google Patents

composições e compostos bicìclicos como inibidores de pdf

Info

Publication number
BRPI0413132A
BRPI0413132A BRPI0413132-0A BRPI0413132A BRPI0413132A BR PI0413132 A BRPI0413132 A BR PI0413132A BR PI0413132 A BRPI0413132 A BR PI0413132A BR PI0413132 A BRPI0413132 A BR PI0413132A
Authority
BR
Brazil
Prior art keywords
compositions
compounds
bicyclic compounds
pdf inhibitors
inhibitors
Prior art date
Application number
BRPI0413132-0A
Other languages
English (en)
Inventor
Valentina Molteni
Xiaohui He
Andreas Kreusch
Juliet Nabakka
Kunyong Yang
Original Assignee
Irm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irm Llc filed Critical Irm Llc
Publication of BRPI0413132A publication Critical patent/BRPI0413132A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçõES E COMPOSTOS BICìCLICOS COMO INIBIDORES DE PDF". A presente invenção refere-se a novos compostos bicíclicos, aos usos destes compostos em várias aplicações medicinais, incluindo tratar distúrbios receptivos a tratamento por inibidores de peptidil desformilase tais como tratamento de infecções bacterianas, e às composições farmacêuticas compreendendo estes compostos.
BRPI0413132-0A 2003-07-31 2004-07-30 composições e compostos bicìclicos como inibidores de pdf BRPI0413132A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49176503P 2003-07-31 2003-07-31
PCT/US2004/024938 WO2005011611A2 (en) 2003-07-31 2004-07-30 Bicyclic compounds and compositions as pdf inhibitors

Publications (1)

Publication Number Publication Date
BRPI0413132A true BRPI0413132A (pt) 2006-10-03

Family

ID=34115548

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413132-0A BRPI0413132A (pt) 2003-07-31 2004-07-30 composições e compostos bicìclicos como inibidores de pdf

Country Status (9)

Country Link
US (2) US7253164B2 (pt)
EP (1) EP1651643A4 (pt)
JP (1) JP2007500728A (pt)
CN (1) CN100471856C (pt)
AU (1) AU2004261283B2 (pt)
BR (1) BRPI0413132A (pt)
CA (1) CA2533824A1 (pt)
MX (1) MXPA06001081A (pt)
WO (1) WO2005011611A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60144284D1 (de) * 2000-11-01 2011-05-05 Millennium Pharm Inc Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
EP1985297A1 (en) * 2006-01-27 2008-10-29 Japan Tobacco, Inc. Carboxylic acid compound and use thereof
US20070197512A1 (en) * 2006-01-27 2007-08-23 Japan Tobacco Inc. Carboxylic Acid Compounds and Use Thereof
JP2016147807A (ja) * 2013-06-04 2016-08-18 日本理化学工業株式会社 ヒドロキサム酸誘導体またはその塩
CN103550217B (zh) * 2013-10-31 2014-12-17 四川大学 一种靶向于细菌rna聚合酶的抗结核小分子化合物
JO3719B1 (ar) 2014-11-20 2021-01-31 Takeda Pharmaceuticals Co 4- أوكسو-4،3- داي هيدرو-3،2،1- بنزوترايازينات كمواد ضابطة لأجل gpr139
AR119971A1 (es) 2019-09-16 2022-01-26 Takeda Pharmaceuticals Co Derivados de piridazin-3(2h)-ona fusionados con azol
EP4146635A1 (en) 2020-05-08 2023-03-15 Takeda Pharmaceutical Company Limited Substituted benzotriazinone metabolites of a gpr139 agonist

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2863864A (en) * 1958-12-09 Chchjconh-
US2851457A (en) * 1956-04-09 1958-09-09 Searle & Co Amidinoalkylbenzothiazinones and processes
US2824102A (en) * 1956-09-13 1958-02-18 Searle & Co Aminoalkyl-2h, 1, 4-benzothiazin-3(4h)-ones
FR1438225A (fr) * 1964-09-24 1966-05-13 Centre Nat Rech Scient Dérivés de la benzothiazine et leur préparation
FR1469476A (fr) * 1965-08-11 1967-02-17 Centre Nat Rech Scient Dérivés de benzothiazine et de benzothiazépine et leur préparation
JPS54109985A (en) * 1978-02-10 1979-08-29 Sumitomo Chem Co Ltd 1,4-benzoazine derivative and bactericidal agent containing the same it component for agriculture and floriculture
US4721784A (en) * 1986-12-22 1988-01-26 Ortho Pharmaceutical Corporation 6-benzoxazinyl-2,3,4,5-tetrahydropyridazin-3-ones
DE3823576A1 (de) * 1988-07-12 1990-01-18 Boehringer Ingelheim Kg Substituierte 3-amino-3,4-dihydrocarbostyrile, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE69016430T2 (de) * 1989-06-09 1995-06-01 Upjohn Co Heterozyklische amine mit zns-wirksamkeit.
JP3358069B2 (ja) * 1991-12-24 2002-12-16 武田薬品工業株式会社 三環性複素環類、その製造法及び剤
US5652245A (en) * 1993-07-27 1997-07-29 Pharmacia & Upjohn Company Heterocyclic amines having central nervous system activity
CN1056612C (zh) * 1994-02-04 2000-09-20 史密丝克莱恩比彻姆有限公司 前手性烯烃的环氧化方法、用于该方法的催化剂
GB9713726D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
EP0994894A1 (en) * 1997-08-11 2000-04-26 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6207687B1 (en) * 1998-07-31 2001-03-27 Merck & Co., Inc. Substituted imidazoles having cytokine inhibitory activity
AU4249700A (en) 1999-04-19 2000-11-02 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivative
EP1229913A4 (en) * 1999-11-18 2005-01-19 Antexpharma Inc SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
US20030105124A1 (en) * 2000-04-27 2003-06-05 Susan Beth Sobolov-Jaynes Substituted benzolactam compounds
JP2002128769A (ja) 2000-10-17 2002-05-09 Sumitomo Pharmaceut Co Ltd ベンゾチアジン−３−オン誘導体
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
MXPA03005668A (es) * 2000-12-21 2004-12-03 Pliva D D Macrolidos.
JP2002332279A (ja) * 2001-05-10 2002-11-22 Senju Pharmaceut Co Ltd ベンゾチアゾリルヒドロキサム酸誘導体およびその用途
JP2004536079A (ja) * 2001-05-16 2004-12-02 アンテックスファーマ・インコーポレーテッド 置換１−ベンズアゼピンおよびその誘導体
AU2002361096A1 (en) 2001-12-27 2003-07-15 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient

Also Published As

Publication number Publication date
WO2005011611A3 (en) 2005-11-03
US7253164B2 (en) 2007-08-07
EP1651643A4 (en) 2008-10-08
AU2004261283A1 (en) 2005-02-10
CA2533824A1 (en) 2005-02-10
US20070259852A1 (en) 2007-11-08
CN100471856C (zh) 2009-03-25
WO2005011611A2 (en) 2005-02-10
CN1860116A (zh) 2006-11-08
EP1651643A2 (en) 2006-05-03
JP2007500728A (ja) 2007-01-18
MXPA06001081A (es) 2006-04-24
US20050197326A1 (en) 2005-09-08
US7579363B2 (en) 2009-08-25
AU2004261283B2 (en) 2008-05-01

Similar Documents

Publication Publication Date Title
ATE313532T1 (de) Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
BRPI0410029B8 (pt) composto dihidroquinazolina substituído, processo para sua preparação, medicamento compreendendo o referido composto e uso do referido composto
BR0207526A (pt) Composto, composição farmacêutica, e, métodos para o tratamento da dor, da enxaqueca, depressão, ansiedade, esquizofrenia, doença de parkinson ou derrame cerebral
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
TR200201094T2 (tr) Farmasötik maddeler olarak bisiklik amino asitler
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
MY133995A (en) 6-phenylpyrrolopyrimidinedione derivatives
ATE462438T1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
BR0311948A (pt) Macrociclos de amida antibacterianos
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
BR0210422A (pt) Compostos bicìclicos de pirrolidina
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
ATE422201T1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
BRPI0418887A (pt) nucleosìdeos de 3-beta-d-ribofuranossiltiazol[4,5-d] pirimidina e usos dos mesmos
BRPI0413132A (pt) composições e compostos bicìclicos como inibidores de pdf
ITMI20030573A1 (it) Composti ad azione nootropica, loro preparazione,
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
BR0112131A (pt) Composições farmacêuticas e métodos para uso
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
PL368040A1 (en) Substituted 4-aminocyclohexanol derivatives
DE502005010850D1 (de) Antibakterielle amid-makrozyklen iv
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. C07D 417/00, 401/00, 279/00, 211/00; A61K 31/4985, 31/5415, 31/438; A61P 31/04

Ipc: C07D 417/00 (2011.01), C07D 401/00 (2011.01), C07D

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2138 DE 27/12/2011.